I am excited to announce that there is now a working prototype for an online, interactive implementation of my Accumulating Evidence and Research Organization (AERO) graph over at (here’s a link to the original methods paper). The goal of this tool is to allow many different research stakeholders (e.g., regulators, ethics committees, patients) to more effectively communicate about the total state of evidence in a given scientific domain and then make more informed decisions on the basis of that evidence. You can check it out here!

About Me

I am a faculty member at the Harvard Center for Bioethics and a research scientist in the Program on Regulation, Therapeutics, and Law at the Brigham and Women’s Hospital in Boston, Massachusetts.

I received my Ph.D. in philosophy from the University of Western Ontario and my B.A. in philosophy from the University of Illinois at Chicago. I previously held a research fellowship in the Biomedical Ethics Unit at McGill University and a visiting scholarship in the Ethox Centre at the University of Oxford.

You can now also follow me on twitter!

Latest Publications

Hey SP, London AJ, Weijer C, Rid A, Miller F (2017). Is The Concept of Clinical Equipoise Still Relevant to Research? BMJ 359:j5787.

Hey SP (2017). Ethical Challenges in Biomarker-Driven Drug Development. Clinical Pharmacology & Therapeutics 103:23-25.

Hey SP, Cohen IG, Adashi EY, Kesselheim AS (2017). Influence, Integrity, and the FDA: An Ethical Framework Science 357(6354):876-877.

Hey SP, Franklin JM, Avorn J, Kesselheim AS (2017). Success, Failure, and Transparency in Biomarker-Based Drug Development: A Case Study of Cholesteryl Ester Transfer Protein Inhibitors Circulation: Cardiovascular Quality and Outcomes 10(6):e003121.

Last updated: December 29, 2017